Sage Therapeutics

• NCT04928703

  Collaborator, Early phase 1, Completed, 33 people, 16 Jun 2021

• Age-Related Trends in Eating-Pathology Symptoms Among Sexual Minority Adults

  Consulting or advice, Fees or honoraria, 8 Dec 2025

• Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

  Consulting or advice, 12 Nov 2025

Sources: pubmed.ncbi.nlm.nih.gov